Be A Freedom Fighter · Bill Library
HR 10810 — National Patient Safety Board Act of 2026
Freedom score: 0 (scale −10 to +10)
- Individual rights: +1
- Property rights: 0
- Economic freedom: 0
- Privacy & due process: +1
- Government power: -2
Sponsor: Rep. Barragán, Nanette Diaz [D-CA-44] · Latest action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (2026-10-15)
Full text on GovInfo (introduced version) · Congress.gov · ← Bill Library index
Findings — 24 highlighted provisions
Each item below is one provision documented in the findings file. The same provision is highlighted in the full text underneath, with its section citation and criterion. Everything else on this page is plain, unreviewed bill text.
- Sec. 2(k) · Individual Rights — Incorporates 15 U.S.C. §2087 protection against discharge or discrimination for employees cooperating with the Board; affects cooperating employees and employers; enforced through the incorporated whistleblower framework See in text ↓
- Sec. 2(h)(3)(B)(iv)(I)-(II) · Property Rights — Study teams must obtain permission before entering participating healthcare facilities or contacting covered personnel; affects healthcare organizations and study teams; no compulsory-entry sanction created See in text ↓
- Sec. 2(j)(1)(A)-(B) · Economic Freedom — Board reports are inadmissible as evidence of liability in specified civil damages cases, but independently obtained data remain usable; affects civil litigants and providers; evidentiary exclusion is enforced by courts See in text ↓
- Sec. 2(j)(2)-(4) · Economic Freedom — Reports may inform standards of care, but HHS may not use Board work product for punitive provider measures and the Board cannot adjudicate rights or liability; limits agency enforcement; no new provider fine See in text ↓
- Sec. 2(c)(2) · Privacy and Due Process — Bars publication identifying patients, providers, or healthcare settings; binds Board officials; statutory confidentiality restriction See in text ↓
- Sec. 2(g)(2) · Privacy and Due Process — Director obtains longitudinal real-time de-identified patient-level safety data from HHS and VA; agency heads must furnish requested data subject to privacy law; administrative duty, with no separate fine See in text ↓
- Sec. 2(g)(3)(A)-(B) · Privacy and Due Process — Creates anonymous or identified safety-report submissions and response mechanism; affects reporters and Board; administrative process See in text ↓
- Sec. 2(g)(4)(A)-(C) · Privacy and Due Process — Provides voluntary data-sharing agreements and submission portal with specified security/privacy frameworks; affects participating organizations; agreement terms and existing privacy law govern See in text ↓
- Sec. 2(g)(5)(A)-(B) · Privacy and Due Process — Requires aggregation and analysis across demographic, facility, and geographic categories; affects Board and data subjects; no standalone private sanction See in text ↓
- Sec. 2(h)(2)(A)-(B) · Privacy and Due Process — Study Division may request and Research Division must share relevant internal data; federal internal information duty See in text ↓
- Sec. 2(h)(3)(B)(iii) · Privacy and Due Process — Study teams cannot disclose information before Board publication; binds teams; confidentiality obligation See in text ↓
- Sec. 2(j)(1)-(4) · Privacy and Due Process — Excludes specified Board work product from liability evidence and forbids punitive agency use; courts and HHS implement the limits See in text ↓
- Sec. 2(a) · Government Power — Creates independent National Patient Safety Board within HHS Secretary’s office; new federal institution See in text ↓
- Sec. 2(b)(1)-(3) · Government Power — Assigns monitoring, causal studies, recommendations, Board approval/revision, and publication duties; binds Board and divisions; no general provider sanctions See in text ↓
- Sec. 2(b)(4)-(5) · Government Power — Requires annual audits and reports to Congress; federal reporting duty See in text ↓
- Sec. 2(c)(1) · Government Power — Authorizes hearings, testimony, evidence, and reports, without express subpoena power See in text ↓
- Sec. 2(d)(1)-(5) · Government Power — Establishes five appointed members, qualifications, staggered five-year terms, conflicts rules, chair and vice chair; governs Board organization See in text ↓
- Sec. 2(e), (f)(1)-(4) · Government Power — Authorizes staff appointments and creates Office of Chair plus research, study, and administrative divisions See in text ↓
- Sec. 2(g)(1)(A)-(D) · Government Power — Requires public-private Health Care Safety Team to develop metrics, identify data sources, and recommend technology with specified stakeholder membership See in text ↓
- Sec. 2(g)(6)(A)-(B), (7)(A)-(C) · Government Power — Requires twice-monthly surveillance briefs, study initiation triggers, and recommendations sent to Board See in text ↓
- Sec. 2(h)(1), (3)(A)-(D) · Government Power — Establishes multidisciplinary study teams, consent, selection guidelines, and optional special board of inquiry for novel infections or pandemics See in text ↓
- Sec. 2(h)(4)(A)-(B), (5) · Government Power — Requires progress and final study reports and HHS/VA responses to recommendations within 90 days See in text ↓
- Sec. 2(i) · Government Power — Creates administrative support responsibilities See in text ↓
- Sec. 2(l)(1)-(2) · Government Power — Defines healthcare settings and patient-safety events, including near misses See in text ↓
Full text (introduced version)
46 of 47 text blocks highlighted. Source: GovInfo, fetched cached.
SECTION 1. SHORT TITLE.
SEC. 2. NATIONAL PATIENT SAFETY BOARD.
Sec. 2(a) · Government Power — Creates independent National Patient Safety Board within HHS Secretary’s office; new federal institution
Sec. 2(b)(1)-(3) · Government Power — Assigns monitoring, causal studies, recommendations, Board approval/revision, and publication duties; binds Board and divisions; no general provider sanctions
Sec. 2(b)(4)-(5) · Government Power — Requires annual audits and reports to Congress; federal reporting duty
Sec. 2(b)(1)-(3) · Government Power — Assigns monitoring, causal studies, recommendations, Board approval/revision, and publication duties; binds Board and divisions; no general provider sanctions
Sec. 2(b)(1)-(3) · Government Power — Assigns monitoring, causal studies, recommendations, Board approval/revision, and publication duties; binds Board and divisions; no general provider sanctions
Sec. 2(b)(1)-(3) · Government Power — Assigns monitoring, causal studies, recommendations, Board approval/revision, and publication duties; binds Board and divisions; no general provider sanctions
Sec. 2(b)(4)-(5) · Government Power — Requires annual audits and reports to Congress; federal reporting duty
Sec. 2(b)(4)-(5) · Government Power — Requires annual audits and reports to Congress; federal reporting duty
Sec. 2(c)(2) · Privacy and Due Process — Bars publication identifying patients, providers, or healthcare settings; binds Board officials; statutory confidentiality restriction
Sec. 2(c)(1) · Government Power — Authorizes hearings, testimony, evidence, and reports, without express subpoena power
Sec. 2(c)(1) · Government Power — Authorizes hearings, testimony, evidence, and reports, without express subpoena power
Sec. 2(c)(2) · Privacy and Due Process — Bars publication identifying patients, providers, or healthcare settings; binds Board officials; statutory confidentiality restriction
Sec. 2(d)(1)-(5) · Government Power — Establishes five appointed members, qualifications, staggered five-year terms, conflicts rules, chair and vice chair; governs Board organization
Sec. 2(d)(1)-(5) · Government Power — Establishes five appointed members, qualifications, staggered five-year terms, conflicts rules, chair and vice chair; governs Board organization
Sec. 2(d)(1)-(5) · Government Power — Establishes five appointed members, qualifications, staggered five-year terms, conflicts rules, chair and vice chair; governs Board organization
Sec. 2(d)(1)-(5) · Government Power — Establishes five appointed members, qualifications, staggered five-year terms, conflicts rules, chair and vice chair; governs Board organization
Sec. 2(d)(1)-(5) · Government Power — Establishes five appointed members, qualifications, staggered five-year terms, conflicts rules, chair and vice chair; governs Board organization
Sec. 2(d)(1)-(5) · Government Power — Establishes five appointed members, qualifications, staggered five-year terms, conflicts rules, chair and vice chair; governs Board organization
Sec. 2(e), (f)(1)-(4) · Government Power — Authorizes staff appointments and creates Office of Chair plus research, study, and administrative divisions
Sec. 2(e), (f)(1)-(4) · Government Power — Authorizes staff appointments and creates Office of Chair plus research, study, and administrative divisions
Sec. 2(e), (f)(1)-(4) · Government Power — Authorizes staff appointments and creates Office of Chair plus research, study, and administrative divisions
Sec. 2(e), (f)(1)-(4) · Government Power — Authorizes staff appointments and creates Office of Chair plus research, study, and administrative divisions
Sec. 2(e), (f)(1)-(4) · Government Power — Authorizes staff appointments and creates Office of Chair plus research, study, and administrative divisions
Sec. 2(e), (f)(1)-(4) · Government Power — Authorizes staff appointments and creates Office of Chair plus research, study, and administrative divisions
Sec. 2(g)(2) · Privacy and Due Process — Director obtains longitudinal real-time de-identified patient-level safety data from HHS and VA; agency heads must furnish requested data subject to privacy law; administrative duty, with no separate fine
Sec. 2(g)(3)(A)-(B) · Privacy and Due Process — Creates anonymous or identified safety-report submissions and response mechanism; affects reporters and Board; administrative process
Sec. 2(g)(4)(A)-(C) · Privacy and Due Process — Provides voluntary data-sharing agreements and submission portal with specified security/privacy frameworks; affects participating organizations; agreement terms and existing privacy law govern
Sec. 2(g)(5)(A)-(B) · Privacy and Due Process — Requires aggregation and analysis across demographic, facility, and geographic categories; affects Board and data subjects; no standalone private sanction
Sec. 2(g)(1)(A)-(D) · Government Power — Requires public-private Health Care Safety Team to develop metrics, identify data sources, and recommend technology with specified stakeholder membership
Sec. 2(g)(6)(A)-(B), (7)(A)-(C) · Government Power — Requires twice-monthly surveillance briefs, study initiation triggers, and recommendations sent to Board
Sec. 2(g)(1)(A)-(D) · Government Power — Requires public-private Health Care Safety Team to develop metrics, identify data sources, and recommend technology with specified stakeholder membership
Sec. 2(g)(2) · Privacy and Due Process — Director obtains longitudinal real-time de-identified patient-level safety data from HHS and VA; agency heads must furnish requested data subject to privacy law; administrative duty, with no separate fine
Sec. 2(g)(3)(A)-(B) · Privacy and Due Process — Creates anonymous or identified safety-report submissions and response mechanism; affects reporters and Board; administrative process
Sec. 2(g)(4)(A)-(C) · Privacy and Due Process — Provides voluntary data-sharing agreements and submission portal with specified security/privacy frameworks; affects participating organizations; agreement terms and existing privacy law govern
Sec. 2(g)(5)(A)-(B) · Privacy and Due Process — Requires aggregation and analysis across demographic, facility, and geographic categories; affects Board and data subjects; no standalone private sanction
Sec. 2(g)(6)(A)-(B), (7)(A)-(C) · Government Power — Requires twice-monthly surveillance briefs, study initiation triggers, and recommendations sent to Board
Sec. 2(g)(6)(A)-(B), (7)(A)-(C) · Government Power — Requires twice-monthly surveillance briefs, study initiation triggers, and recommendations sent to Board
Sec. 2(h)(3)(B)(iv)(I)-(II) · Property Rights — Study teams must obtain permission before entering participating healthcare facilities or contacting covered personnel; affects healthcare organizations and study teams; no compulsory-entry sanction created
Sec. 2(h)(2)(A)-(B) · Privacy and Due Process — Study Division may request and Research Division must share relevant internal data; federal internal information duty
Sec. 2(h)(3)(B)(iii) · Privacy and Due Process — Study teams cannot disclose information before Board publication; binds teams; confidentiality obligation
Sec. 2(h)(1), (3)(A)-(D) · Government Power — Establishes multidisciplinary study teams, consent, selection guidelines, and optional special board of inquiry for novel infections or pandemics
Sec. 2(h)(4)(A)-(B), (5) · Government Power — Requires progress and final study reports and HHS/VA responses to recommendations within 90 days
Sec. 2(h)(1), (3)(A)-(D) · Government Power — Establishes multidisciplinary study teams, consent, selection guidelines, and optional special board of inquiry for novel infections or pandemics
Sec. 2(h)(2)(A)-(B) · Privacy and Due Process — Study Division may request and Research Division must share relevant internal data; federal internal information duty
Sec. 2(h)(3)(B)(iv)(I)-(II) · Property Rights — Study teams must obtain permission before entering participating healthcare facilities or contacting covered personnel; affects healthcare organizations and study teams; no compulsory-entry sanction created
Sec. 2(h)(3)(B)(iii) · Privacy and Due Process — Study teams cannot disclose information before Board publication; binds teams; confidentiality obligation
Sec. 2(h)(1), (3)(A)-(D) · Government Power — Establishes multidisciplinary study teams, consent, selection guidelines, and optional special board of inquiry for novel infections or pandemics
Sec. 2(h)(4)(A)-(B), (5) · Government Power — Requires progress and final study reports and HHS/VA responses to recommendations within 90 days
Sec. 2(h)(4)(A)-(B), (5) · Government Power — Requires progress and final study reports and HHS/VA responses to recommendations within 90 days
Sec. 2(i) · Government Power — Creates administrative support responsibilities
Sec. 2(j)(1)(A)-(B) · Economic Freedom — Board reports are inadmissible as evidence of liability in specified civil damages cases, but independently obtained data remain usable; affects civil litigants and providers; evidentiary exclusion is enforced by courts
Sec. 2(j)(2)-(4) · Economic Freedom — Reports may inform standards of care, but HHS may not use Board work product for punitive provider measures and the Board cannot adjudicate rights or liability; limits agency enforcement; no new provider fine
Sec. 2(j)(1)-(4) · Privacy and Due Process — Excludes specified Board work product from liability evidence and forbids punitive agency use; courts and HHS implement the limits
Sec. 2(j)(1)(A)-(B) · Economic Freedom — Board reports are inadmissible as evidence of liability in specified civil damages cases, but independently obtained data remain usable; affects civil litigants and providers; evidentiary exclusion is enforced by courts
Sec. 2(j)(1)-(4) · Privacy and Due Process — Excludes specified Board work product from liability evidence and forbids punitive agency use; courts and HHS implement the limits
Sec. 2(j)(2)-(4) · Economic Freedom — Reports may inform standards of care, but HHS may not use Board work product for punitive provider measures and the Board cannot adjudicate rights or liability; limits agency enforcement; no new provider fine
Sec. 2(j)(1)-(4) · Privacy and Due Process — Excludes specified Board work product from liability evidence and forbids punitive agency use; courts and HHS implement the limits
Sec. 2(j)(2)-(4) · Economic Freedom — Reports may inform standards of care, but HHS may not use Board work product for punitive provider measures and the Board cannot adjudicate rights or liability; limits agency enforcement; no new provider fine
Sec. 2(j)(1)-(4) · Privacy and Due Process — Excludes specified Board work product from liability evidence and forbids punitive agency use; courts and HHS implement the limits
Sec. 2(j)(2)-(4) · Economic Freedom — Reports may inform standards of care, but HHS may not use Board work product for punitive provider measures and the Board cannot adjudicate rights or liability; limits agency enforcement; no new provider fine
Sec. 2(j)(1)-(4) · Privacy and Due Process — Excludes specified Board work product from liability evidence and forbids punitive agency use; courts and HHS implement the limits
Sec. 2(k) · Individual Rights — Incorporates 15 U.S.C. §2087 protection against discharge or discrimination for employees cooperating with the Board; affects cooperating employees and employers; enforced through the incorporated whistleblower framework
Sec. 2(l)(1)-(2) · Government Power — Defines healthcare settings and patient-safety events, including near misses
Sec. 2(l)(1)-(2) · Government Power — Defines healthcare settings and patient-safety events, including near misses
Sec. 2(l)(1)-(2) · Government Power — Defines healthcare settings and patient-safety events, including near misses
Findings source: bill-scores-v2-batch37-findings-2026-11-14.md. Highlights come only from that file; no finding, score, or provision was invented for this page.
What you can do
Contact your U.S. Representative and Senators about this bill.
Find your Representative Contact your Senators
Spot an error on this page? Report it.